Sildenafil therapy in bronchopulmonary dysplasia-associated pulmonary hypertension: a retrospective study of efficacy and safety

[1]  P. Smith,et al.  Safety of Sildenafil in Infants* , 2014, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[2]  S. McGrath-Morrow,et al.  Health-care utilization and respiratory morbidities in preterm infants with pulmonary hypertension , 2013, Journal of Perinatology.

[3]  K. J. Guy,et al.  The effect of sildenafil on retinopathy of prematurity in very preterm infants , 2013, Journal of Perinatology.

[4]  W. Carlo,et al.  Prospective Analysis of Pulmonary Hypertension in Extremely Low Birth Weight Infants , 2012, Pediatrics.

[5]  J. Slaughter,et al.  Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation , 2011, Journal of Perinatology.

[6]  D. Celermajer,et al.  Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. , 2011, European heart journal.

[7]  E. Bae,et al.  Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia , 2010, Korean circulation journal.

[8]  P. McNamara,et al.  Effects of Rho-Kinase Inhibition on Pulmonary Hypertension, Lung Growth, and Structure in Neonatal Rats Chronically Exposed to Hypoxia , 2010, Pediatric Research.

[9]  F. Walther,et al.  Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury , 2009, Respiratory research.

[10]  P. Mourani,et al.  Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. , 2009, The Journal of pediatrics.

[11]  D. McElhinney,et al.  Pulmonary Artery Hypertension in Formerly Premature Infants With Bronchopulmonary Dysplasia: Clinical Features and Outcomes in the Surfactant Era , 2007, Pediatrics.

[12]  L. Sivaswamy,et al.  Ischemic optic neuropathy in a child. , 2007, Pediatric neurology.

[13]  G. Korbutt,et al.  Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. , 2005, American journal of respiratory and critical care medicine.

[14]  D. Stephens,et al.  Beneficial Effect of Oral Sildenafil Therapy on Childhood Pulmonary Arterial Hypertension: Twelve-Month Clinical Trial of a Single-Drug, Open-Label, Pilot Study , 2005, Circulation.

[15]  G. Maislin,et al.  Vasodilator therapy for primary pulmonary hypertension in children. , 1999, Circulation.

[16]  N. Evans,et al.  Doppler assessment of pulmonary artery pressure and extrapulmonary shunting in the acute phase of hyaline membrane disease. , 1991, Archives of disease in childhood.

[17]  H. Whyte,et al.  Doppler echocardiographic measurement of pulmonary artery pressure from ductal Doppler velocities in the newborn. , 1990, Journal of the American College of Cardiology.

[18]  R. Barst.  Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension. , 1986, Chest.

[19]  A. Weyman,et al.  Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: a cross-sectional echocardiographic study. , 1983, Circulation.

[20]  R. Burstein,et al.  Evaluation of infants with bronchopulmonary dysplasia using cardiac catheterization. , 1982, Pediatrics.

[21]  J. Fouron,et al.  Value of echocardiography in assessing the outcome of bronchopulmonary dysplasia of the newborn. , 1980, Pediatrics.

[22]  E. Bancalari,et al.  Prevention of Bronchopulmonary Dysplasia: Are Intratracheal Steroids with Surfactant a Magic Bullet? , 2016, American journal of respiratory and critical care medicine.

[23]  B. Poindexter,et al.  Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. , 2015, American journal of respiratory and critical care medicine.

[24]  W. Truog,et al.  Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits? , 2012, Journal of Perinatology.

[25]  M. Pillinger,et al.  Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension , 2006 .

[26]  E. Bancalari,et al.  Bronchopulmonary dysplasia. , 1986, Pediatric clinics of North America.

[27]  H. Palevsky,et al.  Vasodilator therapy for primary pulmonary hypertension. , 1985, Annual review of medicine.